Kansara Viral, Luo Shuanghui, Balasubrahmanyam Budda, Pal Dhananjay, Mitra Ashim K
Division of Pharmaceutical Sciences, School of Pharmacy, University of Missouri Kansas city, 5005 Rockhill Road, Kansas city, MO 64110-2499, USA.
Int J Pharm. 2006 Apr 7;312(1-2):43-52. doi: 10.1016/j.ijpharm.2005.12.045. Epub 2006 Feb 3.
The objective of this research was to investigate the presence of a specialized carrier-mediated system for biotin and delineate uptake mechanism and intracellular trafficking of biotin in the human derived retinoblastoma cell line (Y-79). Human derived retinoblastoma cell line, Y-79, was used for uptake studies. Uptake of [3H]Biotin was determined at various concentrations, pH, temperatures, in the absence of sodium and in the presence of other vitamins and metabolic inhibitors to delineate the mechanism of uptake. Uptake was determined in the presence of various intracellular regulatory pathways (protein kinase A & C, protein tyrosine kinase and calcium-calmodulin) modulators. Reverse transcription polymerase chain reaction (RT-PCR) was performed to confirm the molecular identity of human sodium-dependent multivitamin transporter (hSMVT). Uptake of [3H]Biotin in Y-79 cells were found to be saturable at micromolar concentration range, with apparent Km of 8.53 microM and Vmax of 14.12 pmol/min/mg protein, but linear at nanomolar concentration range. Uptake was sodium, pH, temperature and energy-dependent, but chloride independent; inhibited by the structural analogue desthiobiotin, pantothenic acid and lipoic acid at milimolar concentrations and not at nanomolar concentrations. Uptake of [3H]Biotin was trans-stimulated by the intracellular biotin. Ca2+/calmodulin pathways appeared to play important roles in the regulation of riboflavin uptake in Y-79 cells via significant reduction in Vmax (66%) and Km (28%) of the uptake process. A human sodium-dependant multivitamin transporter, hSMVT, was identified by RT-PCR in Y-79. These studies demonstrated for the first time the existence of a human sodium dependant multivitamin transporter (hSMVT), a specialized carrier-mediated system for biotin uptake, in human derived retinoblastoma cells.
本研究的目的是调查生物素是否存在专门的载体介导系统,并描述生物素在人源视网膜母细胞瘤细胞系(Y-79)中的摄取机制和细胞内转运情况。人源视网膜母细胞瘤细胞系Y-79用于摄取研究。在不同浓度、pH值、温度下,在无钠以及存在其他维生素和代谢抑制剂的情况下,测定[3H]生物素的摄取量,以描述摄取机制。在存在各种细胞内调节途径(蛋白激酶A和C、蛋白酪氨酸激酶以及钙调蛋白)调节剂的情况下测定摄取量。进行逆转录聚合酶链反应(RT-PCR)以确认人钠依赖性多种维生素转运蛋白(hSMVT)的分子身份。发现Y-79细胞中[3H]生物素的摄取在微摩尔浓度范围内是可饱和的,表观Km为8.53微摩尔,Vmax为14.12皮摩尔/分钟/毫克蛋白,但在纳摩尔浓度范围内呈线性。摄取是钠、pH值、温度和能量依赖性的,但与氯离子无关;在毫摩尔浓度下,摄取受到结构类似物脱硫生物素、泛酸和硫辛酸的抑制,而在纳摩尔浓度下则不受抑制。细胞内生物素对[3H]生物素的摄取有反刺激作用。Ca2+/钙调蛋白途径似乎在调节Y-79细胞中核黄素摄取方面发挥重要作用,通过使摄取过程的Vmax(66%)和Km(28%)显著降低来实现。通过RT-PCR在Y-79中鉴定出一种人钠依赖性多种维生素转运蛋白hSMVT。这些研究首次证明在人源视网膜母细胞瘤细胞中存在人钠依赖性多种维生素转运蛋白(hSMVT),这是一种专门的生物素摄取载体介导系统。